Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis-Associated PAH”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableLooking for participantsNCT07236970
What this trial is testing

Multicenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligence for Patients With Systemic Sclerosis

Who this might be right for
Pulmonary HypertensionSystemic Sclerosis (SSc)Systemic Sclerosis-Associated PAH
Alejandro Cruz Utrilla 350
Testing effectiveness (Phase 2)Study completedNCT01086540
What this trial is testing

Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)

Who this might be right for
Systemic Sclerosis-Associated PAH
National Institute of Allergy and Infectious Diseases (NIAID) 57
Not applicableEnded earlyNCT02169752
What this trial is testing

Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension

Who this might be right for
Pre-Pulmonary Atrial Hypertension
National Jewish Health 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT02682511
What this trial is testing

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

Who this might be right for
Scleroderma, DiffuseScleroderma, SystemicScleroderma, Limited+5 more
Cumberland Pharmaceuticals 34
Post-approval studies (Phase 4)Study completedNCT01042158
What this trial is testing

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis

Who this might be right for
Pulmonary Arterial HypertensionSystemic SclerosisScleroderma Spectrum of Diseases+2 more
Johns Hopkins University 25
Not applicableStudy completedNCT03889509
What this trial is testing

A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic Sclerosis

Who this might be right for
Pulmonary Arterial HypertensionSystemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 63
Testing effectiveness (Phase 2)Study completedNCT02290613
What this trial is testing

Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH)

Who this might be right for
Systemic SclerosisPulmonary Hypertension
Heidelberg University 38
Early research (Phase 1)Ended earlyNCT02981082
What this trial is testing

Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

Who this might be right for
Systemic SclerosisPulmonary; Hypertension
Robert Lafyatis 6
Post-approval studies (Phase 4)UnknownNCT03053739
What this trial is testing

To Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic Sclerosis

Who this might be right for
Associated Pulmonary Arterial Hypertension
Post Graduate Institute of Medical Education and Research, Chandigarh 50
Not applicableLooking for participantsNCT01884051
What this trial is testing

Hormonal, Metabolic, and Signaling Interactions in PAH

Who this might be right for
Idiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial HypertensionScleroderma Associated Pulmonary Arterial Hypertension+1 more
Vanderbilt University Medical Center 1,899